Paper24901013
Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis.
Meira M and 7 others. J Immunol Res, 2014. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis. Papers, record 24901013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24901013
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis.
- PubMed
Topics28
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal, Humanized | Major topic |
| CD4-Positive T-Lymphocytes | Major topic |
| Gene Expression Regulation | Major topic |
| MicroRNAs | Major topic |
| Multiple Sclerosis, Relapsing-Remitting | Major topic |
| Adult | |
| Apoptosis Regulatory Proteins | |
| Bcl-2-Like Protein 11 | |
| Case-Control Studies | |
| Cell Cycle | |
| Cell Migration Inhibition | |
| Cell Movement | |
| Cell Proliferation | |
| Cyclin-Dependent Kinase Inhibitor p21 | |
| E2F1 Transcription Factor | |
| Female | |
| Humans | |
| Lymphocyte Activation | |
| Male | |
| Membrane Proteins | |
| Middle Aged | |
| Natalizumab | |
| PTEN Phosphohydrolase | |
| Protein Serine-Threonine Kinases | |
| Proto-Oncogene Proteins | |
| Receptor, Transforming Growth Factor-beta Type II | |
| Receptors, Transforming Growth Factor beta | |
| Signal Transduction |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23109880 | Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. | Int J Mol Sci | 2012 | https://conductscience.org/library/papers/23109880 | PubMed |
| 2 | 12915464 | Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease. | Hum Mol Genet | 2003 | https://conductscience.org/library/papers/12915464 | PubMed |
| 3 | 10449105 | The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. | Neurology | 1999 | https://conductscience.org/library/papers/10449105 | PubMed |
| 4 | 18329372 | Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. | Cell | 2008 | https://conductscience.org/library/papers/18329372 | PubMed |
| 5 | 20505758 | microRNA expression patterns reveal differential expression of target genes with age. | PLoS One | 2010 | https://conductscience.org/library/papers/20505758 | PubMed |
| 6 | 22659298 | Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. | Clin Immunol | 2012 | https://conductscience.org/library/papers/22659298 | PubMed |
| 7 | 17897326 | Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. | Immunology | 2008 | https://conductscience.org/library/papers/17897326 | PubMed |
| 8 | 20637509 | Altered miRNA expression in T regulatory cells in course of multiple sclerosis. | J Neuroimmunol | 2010 | https://conductscience.org/library/papers/20637509 | PubMed |
| 9 | 17135268 | Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17135268 | PubMed |
| 10 | 18922889 | Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. | Cancer Res | 2008 | https://conductscience.org/library/papers/18922889 | PubMed |
| 11 | 20148420 | Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. | Eur J Immunol | 2010 | https://conductscience.org/library/papers/20148420 | PubMed |
| 12 | 18327259 | Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. | Nat Immunol | 2008 | https://conductscience.org/library/papers/18327259 | PubMed |
| 13 | 21972292 | Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. | Blood | 2011 | https://conductscience.org/library/papers/21972292 | PubMed |
| 14 | 11371355 | T cell-specific loss of Pten leads to defects in central and peripheral tolerance. | Immunity | 2001 | https://conductscience.org/library/papers/11371355 | PubMed |
| 15 | 23202949 | MicroRNAs as active players in the pathogenesis of multiple sclerosis. | Int J Mol Sci | 2012 | https://conductscience.org/library/papers/23202949 | PubMed |
| 16 | 23346094 | MicroRNA dysregulation in multiple sclerosis. | Front Genet | 2012 | https://conductscience.org/library/papers/23346094 | PubMed |
| 17 | 18328430 | E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. | Cancer Cell | 2008 | https://conductscience.org/library/papers/18328430 | PubMed |
| 18 | 23709210 | Natalizumab therapy for multiple sclerosis. | Semin Neurol | 2013 | https://conductscience.org/library/papers/23709210 | PubMed |
| 19 | 23152504 | Bim, a proapoptotic protein, up-regulated via transcription factor E2F1-dependent mechanism, functions as a prosurvival molecule in cancer. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23152504 | PubMed |
| 20 | 21151203 | The emerging role of microRNAs in multiple sclerosis. | Nat Rev Neurol | 2011 | https://conductscience.org/library/papers/21151203 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42148108 | Interplay between microRNAs and TGF-β signaling in T cells: implications for Th9 differentiation and immune pathogenesis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42148108 | PubMed |
| 41953255 | Impaired myelination in multiple sclerosis organoids: p21 links oligodendrocyte dysfunction to disease subtype. | Front Cell Neurosci | 2026 | https://conductscience.org/library/papers/41953255 | PubMed |
| 38474262 | Targeted RNAseq Revealed the Gene Expression Signature of Ferroptosis-Related Processes Associated with Disease Severity in Patients with Multiple Sclerosis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474262 | PubMed |
| 38193092 | The role of microRNAs involved in the disorder of blood-brain barrier in the pathogenesis of multiple sclerosis. | Front Immunol | 2023 | https://conductscience.org/library/papers/38193092 | PubMed |
| 37715885 | Natalizumab Treatment of Relapsing Remitting Multiple Sclerosis Has No Long-Term Effects on the Proportion of Circulating Regulatory T Cells. | Neurol Ther | 2023 | https://conductscience.org/library/papers/37715885 | PubMed |
| 36818652 | Women in the field of multiple sclerosis: How they contributed to paradigm shifts. | Front Mol Neurosci | 2023 | https://conductscience.org/library/papers/36818652 | PubMed |
| 35774792 | microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate. | Front Immunol | 2022 | https://conductscience.org/library/papers/35774792 | PubMed |
| 34484645 | An Integrated Bioinformatics Analysis of the Potential Regulatory Effects of miR-21 on T-cell Related Target Genes in Multiple Sclerosis. | Avicenna J Med Biotechnol | 2021 | https://conductscience.org/library/papers/34484645 | PubMed |
| 34039371 | miR-20a suppresses Treg differentiation by targeting Map3k9 in experimental autoimmune encephalomyelitis. | J Transl Med | 2021 | https://conductscience.org/library/papers/34039371 | PubMed |
| 33716981 | Nuclear Receptors in the Control of the NLRP3 Inflammasome Pathway. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/33716981 | PubMed |
| 33322628 | The Relationship of the Mechanisms of the Pathogenesis of Multiple Sclerosis and the Expression of Endogenous Retroviruses. | Biology (Basel) | 2020 | https://conductscience.org/library/papers/33322628 | PubMed |
| 32009827 | Environmental Influencers, MicroRNA, and Multiple Sclerosis. | J Cent Nerv Syst Dis | 2020 | https://conductscience.org/library/papers/32009827 | PubMed |
| 31915697 | Identification of Monotonically Differentially Expressed Genes for IFN-β-Treated Multiple Sclerosis Patients. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/31915697 | PubMed |
| 31897308 | PARP-1 deregulation in multiple sclerosis. | Mult Scler J Exp Transl Clin | 2019 | https://conductscience.org/library/papers/31897308 | PubMed |
| 31892254 | Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World. | Cells | 2019 | https://conductscience.org/library/papers/31892254 | PubMed |
| 31721043 | Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment. | Mol Neurobiol | 2020 | https://conductscience.org/library/papers/31721043 | PubMed |
| 30319616 | Control of Immunoregulatory Molecules by miRNAs in T Cell Activation. | Front Immunol | 2018 | https://conductscience.org/library/papers/30319616 | PubMed |
| 30047100 | Do Human Endogenous Retroviruses Contribute to Multiple Sclerosis, and if So, How? | Mol Neurobiol | 2019 | https://conductscience.org/library/papers/30047100 | PubMed |
| 29915595 | Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation. | Front Immunol | 2018 | https://conductscience.org/library/papers/29915595 | PubMed |
| 29774781 | Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients. | Mult Scler | 2018 | https://conductscience.org/library/papers/29774781 | PubMed |
Genes32
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24901013
GET https://conductscience.org/api/papers/v1/24901013/references?page=2